Table 3 Association between changes in the priority of pain and mean levels (95% CI) of patient‐perceived pain and disease activity.

	3 months				12 months
	P/P (n = 112)	NP/P (n = 10)	P/NP (n = 41)	NP/NP (n = 10)	P/P (n = 96)	NP/P (n = 27)	P/NP (n = 26)	NP/NP (n = 24)
AIMS2 Pain	5.0 (4.6 to 5.4)	6.2 (4.3 to 8.0)*	3.4 (2.7 to 4.1)†	2.9 (1.5 to 4.3)	5.2 (4.7 to 5.6)	5.0 (4.2 to 5.7)*	3.7 (2.6 to 4.7)†	2.3 (1.7 to 3.0)
RADAI	3.9 (3.5 to 4.2)	5.3 (3.7 to 6.8)*	2.9 (2.3 to 3.5)†	3.3 (2.3 to 4.3)	3.6 (3.2 to 4.0)	3.5 (2.8 to 4.3)*	2.6 (1.8 to 3.3)†	2.0 (1.2 to 2.7)

AIMS2, Arthritis Impact Measurement Scales;NP/NP, no priority to no priority; NP/P, no priority to priority; P/NP, priority to no priority; P/P, priority to priority; RADAI, Rheumatoid Arthritis Disease Activity Index.

*Significantly different from NP/NP (p<0.05).

†Significantly different from P/P (p<0.05).